← Back to search
OPHIREX, INC
CORTE MADERA, CA, 94925
Unclaimed
AI-Generated Company Overview
Generating overview from available records...
Source Records
No company-reported description yet. Owners can add one after claiming the profile.
Capabilities
Derived from government recordsGov-sourced
Prime contracting experience
4 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Defense Defense Health Agency | COVID-19 DHA 2018.1 SBIR PHASE III MEDICAL R&D CONTRACT PROPOSAL TITLED: "TARGETING SPLA2 FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) ASSOCIATED WITH SARS-COV-2" LOG #19000053 W81XWH20C0066 | — | $9,926,612 | Sep 5, 2025 | Jun 19, 2020 – Sep 29, 2023 |
| Prime | Department of Defense Defense Health Agency | FOLLOW ON PHASE III RESEARCH AND DEVELOPMENT SBIR FOR PROJECT TITLED, BROAD-SPECTRUM SNAKEBITE ANTIDOTE: ORAL PRODUCT DEVELOPMENT AND IV CLINICAL STUDY W81XWH22C0030 | — | $23,443,944 | Mar 19, 2024 | Apr 5, 2022 – Dec 4, 2025 |
| Prime | Department of Defense Defense Health Agency | DHA PH II SEQL PROPOSAL H2S-0045, TITLE: BROAD-SPECTRUM SNAKEBITE ANTIDOTE: METALLOPROTEASE INHIBITION TO IMPROVE RECOVERY TIME FOLLOWING SNAKEBITE, MEDICAL R & D EGS 23000510 HT942523C0061 | — | $1,299,779 | Oct 30, 2023 | Aug 25, 2023 – Dec 24, 2025 |
| Prime | Department of Defense Defense Health Agency | ARMY MEDICAL RESEARCH AND DEVELOPMENT SBIR PHASE III CONTRACT TITLED ADVANCEMENT OF ADVANCEMENT BROAD-SPECTRUM SNAKEBITE ANTIDOTE. W81XWH20C0017 | — | $9,407,618 | Aug 23, 2023 | Jun 1, 2020 – Apr 30, 2024 |
Contract vehicles are shown only when present in the source record.
Subcontracting experience
No subaward records on record in current sources. Subcontract relationships are never inferred from award keywords.
Agencies supported
- Department of DefenseGov-sourced